I have had a small position in Sarepta for a while and it just occurred to me that all of the bashers are essentially gone now that their first exon skipping drug was approved a year ago and the second exon version recently demonstrated similar results. There was heavy negativity just like now with IPIX.....the good news is IPIX has multiple shots on goal and it is likely that in a few short months the bashers will be but a memory
(6)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links